Your session is about to expire
← Back to Search
Study Summary
This trial is testing if identifying and intervening with patients at high risk for disengagement in coordinated specialty care (CSC) can prevent or delay disengagement.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- N/A
- Group 1: CSC Step-down intervention
- Group 2: Usual Care
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom does this clinical trial offer eligibility?
"This research requires 300 patients with polytetrafluoroethylene who are aged 15 to 40 years of age. Notably, eligibility is contingent on the individual being enrolled in a CSC program."
What potential hazards might this treatment carry for individuals?
"The safety of this treatment is rated as a 3, due to the fact that it has reached Phase 4 trials and thus been approved by regulators."
Are there opportunities for people to join this investigation?
"Absolutely. Clinicaltrials.gov provides evidence that this medical investigation is presently recruiting participants, with the trial having first been advertised on July 1st 2020 and updated most recently on September 27th 2022. Three sites are searching to enroll 300 individuals in total."
How many participants are being welcomed into this research project?
"Affirmative, the information on clinicaltrials.gov states that this investigation is actively searching for participants. It was published online on the first of July 2020 and modified lastly in September 2022. 300 subjects are required from 3 different research sites."
Is eligibility for this experiment restricted to individuals under 40 years of age?
"According to the trial's inclusion criteria, participants must fall between 15 and 40 years old; there are 68 studies for minors, and 97 trials designed for the elderly."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger